We highly value your continued support of DRG products and services. In the context of improving our overall customer satisfaction and providing you with compelling and exciting new products, we invite you to complete this short questionnaire.
I would like to confirm that all survey responses and feedback will be kept confidential and may be completed anonymously.
Thank you very much for your cooperation!
Eric van Bladel, COO
News and Updates
DRG:HYBRiD-XL® Summer Workshop Recap
On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees...
New sTfR (Soluble Transferrin Receptor) ELISA launched by DRG
DRG is proud to announce the launch of a NEW assay kit as part of DRG's Iron Panel: sTfR ELISA RUO (EIA-5925R).Specifications of the new assay kit sTfR ELISA RUO, EIA-5925R:Principle of the Assay: ELISA based on the sandwich principleAssay Range: 0.145 – 160...
Salivary Hepcidin ELISA: NEW and UNIQUE assay launched by DRG!
DRG is proud to announce the launch of a NEW and UNIQUE assay kit of DRG's Iron Panel: Salivary Hepcidin RUO (SLV-6082R).The hormone hepcidin plays an important role in regulating iron metabolism. It is a major regulator of dietary iron absorption and iron...
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.